Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)

v3.23.1
BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)
3 Months Ended
Mar. 31, 2023
USD ($)
Integer
U.S. Patents owned by the company 97
Expired patents 52
Foreign patents owned by the company 8
I Li A D Biotechnologies L L C [Member]  
Aggregate investment amount | $ $ 7,000,000
Patents owned by ILiAD 65